Pathogenesis and management of polymicrobial infections due to aerobic and anaerobic bacteria.
Brook
I
I
Department of Pediatrics, Georgetown University, School of Medicine, Washington, D.C. 20016.
D000818:Animals; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001420:Bacteria, Aerobic / Q000201:enzymology / Q000472:pathogenicity; D001421:Bacteria, Anaerobic / Q000201:enzymology / Q000472:pathogenicity; D016667:Bacterial Capsules / Q000502:physiology; D001424:Bacterial Infections / Q000188:drug therapy* / Q000209:etiology*; D001439:Bacteroides / Q000201:enzymology / Q000472:pathogenicity; D001442:Bacteroides Infections / Q000188:drug therapy / Q000209:etiology; D006801:Humans; D014774:Virulence; D001618:beta-Lactamases / Q000096:biosynthesis
D000900:Anti-Bacterial Agents; D001618:beta-Lactamases